MARKET

NCNA

NCNA

NuCana
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.00
+0.30
+3.90%
Closed 16:00 09/20 EDT
OPEN
7.84
PREV CLOSE
7.70
HIGH
8.00
LOW
7.60
VOLUME
17.97K
TURNOVER
--
52 WEEK HIGH
25.82
52 WEEK LOW
4.010
MARKET CAP
254.49M
P/E (TTM)
-12.7898
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NCNA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NCNA News

  • What Percentage Of NuCana plc (NASDAQ:NCNA) Shares Do Insiders Own?
  • Simply Wall St..2d ago
  • Seattle Genetics' Enfortumab Vedotin BLA Gets Priority Review
  • Zacks.5d ago
  • FDA Grants Orphan Drug Status to Acceleron's PAH Candidate
  • Zacks.09/10 23:00
  • NuCana plc (NCNA) Shares March Higher, Can It Continue?
  • Zacks.09/06 14:06

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About NCNA

NuCana PLC is a clinical-stage biopharmaceutical company. The Company is focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The Company utilizes its ProTide technology to develop medicines to overcome cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Its pipeline of products includes Acelarin, NUC-3373 and NUC-7738. Acelarin is a nucleotide analog and is a ProTide transformation of gemcitabine for the treatment of cancer. The Company is evaluating Acelarin in four clinical trials across several solid tumor indications. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil for the treatment of a wide range of cancers. NUC-3373 is in a Phase I trial for the potential treatment of a wide range of solid tumor cancers. NUC-7738 is a ProTide transformation of cordycepin, a novel nucleoside analog.
More

Webull offers NuCana PLC (ADR) (NCNA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.